VASEXTEN Modified release capsules (2013)
Active ingredients: Barnidipine
Product Name and Form
Vasexten 10, 10 mg modified release capsules.
Modified release capsules, hard.
Vasexten 10 modified release capsules are yellow and marked: 155 10
Qualitative and Quantitative Composition
Vasexten contains barnidipine hydrochloride.
Vasexten 10 modified release capsules, hard, contain 10 mg barnidipine hydrochloride, equivalent to 9.3 mg barnidipine per capsule.
Excipients with known effect: sucrose 95 mg.
For the full list of excipients, see section 6.1
The excipients of Vasexten capsules are:
Capsule content: carboxymethylethylcellulose, polysorbate 80, sucrose, ethylcellulose, talc.
Capsule shell: titanium dioxide (E171), yellow iron oxide (E172) and gelatine.
Printing ink: shellac, propylene glycol (E1520), black iron oxide (E172), ammonia.
Pack sizes and Marketing
Vasexten modified release capsules are packed in boxes containing 10, 14, 20, 28, 30, 50, 56, 98 or 100 capsules in aluminium-aluminium (with PVC and polyamide coating) blisters. A blister contains 7, 10 or 14 capsules.
Not all pack sizes may be marketed.
Astellas Pharma Europe B.V., Sylviusweg 62, 2333 BE Leiden, The Netherlands